New insights in the pathophysiology of ovarian cancer and implications for screening and prevention

Farr R. Nezhat, Radu Apostol, Camran Nezhat, Tanja Pejovic

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological malignancies. Herein we present the latest information on the pathophysiology of ovarian cancer and its significance for ovarian cancer screening and prevention. A new paradigm for ovarian cancer pathogenesis presupposes 2 distinct types of ovarian epithelial carcinoma with distinct molecular profiles: type I and type II carcinomas. Type I tumors include endometrioid, clear-cell carcinoma, and low-grade serous carcinoma and mostly arise via defined sequence either from endometriosis or from borderline serous tumors, mostly presenting in an early stage. More frequent type II carcinomas are usually high-grade serous tumors, and recent evidence suggests that the majority arise from the fimbriated end of the fallopian tube. Subsequently, high-grade serous carcinomas usually present at advanced stages, likely as a consequence of the rapid peritoneal seeding from the open ends of the fallopian tubes. On the other hand, careful clinical evaluation should be performed along with risk stratification and targeted treatment of women with premalignant conditions leading to type I cancers, most notably endometriosis and endometriomas. Although the chance of malignant transformation is low, an understanding of this link offers a possibility of prevention and early intervention. This new evidence explains difficulties in ovarian cancer screening and helps in forming new recommendations for ovarian cancer risk evaluation and prophylactic treatments.

Original languageEnglish (US)
Pages (from-to)262-267
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume213
Issue number3
DOIs
StatePublished - Sep 1 2015

Fingerprint

Early Detection of Cancer
Ovarian Neoplasms
Carcinoma
Endometriosis
Fallopian Tubes
Neoplasms
Medicine
Therapeutics

Keywords

  • endometriosis
  • fallopian tube
  • ovarian cancer
  • prevention
  • risk-reducing bilateral salpingo-oophorectomy
  • salpingectomy
  • screening

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. / Nezhat, Farr R.; Apostol, Radu; Nezhat, Camran; Pejovic, Tanja.

In: American Journal of Obstetrics and Gynecology, Vol. 213, No. 3, 01.09.2015, p. 262-267.

Research output: Contribution to journalArticle

@article{fd163c1c8ba4403e8ad7ea3d8f882d53,
title = "New insights in the pathophysiology of ovarian cancer and implications for screening and prevention",
abstract = "Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological malignancies. Herein we present the latest information on the pathophysiology of ovarian cancer and its significance for ovarian cancer screening and prevention. A new paradigm for ovarian cancer pathogenesis presupposes 2 distinct types of ovarian epithelial carcinoma with distinct molecular profiles: type I and type II carcinomas. Type I tumors include endometrioid, clear-cell carcinoma, and low-grade serous carcinoma and mostly arise via defined sequence either from endometriosis or from borderline serous tumors, mostly presenting in an early stage. More frequent type II carcinomas are usually high-grade serous tumors, and recent evidence suggests that the majority arise from the fimbriated end of the fallopian tube. Subsequently, high-grade serous carcinomas usually present at advanced stages, likely as a consequence of the rapid peritoneal seeding from the open ends of the fallopian tubes. On the other hand, careful clinical evaluation should be performed along with risk stratification and targeted treatment of women with premalignant conditions leading to type I cancers, most notably endometriosis and endometriomas. Although the chance of malignant transformation is low, an understanding of this link offers a possibility of prevention and early intervention. This new evidence explains difficulties in ovarian cancer screening and helps in forming new recommendations for ovarian cancer risk evaluation and prophylactic treatments.",
keywords = "endometriosis, fallopian tube, ovarian cancer, prevention, risk-reducing bilateral salpingo-oophorectomy, salpingectomy, screening",
author = "Nezhat, {Farr R.} and Radu Apostol and Camran Nezhat and Tanja Pejovic",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.ajog.2015.03.044",
language = "English (US)",
volume = "213",
pages = "262--267",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - New insights in the pathophysiology of ovarian cancer and implications for screening and prevention

AU - Nezhat, Farr R.

AU - Apostol, Radu

AU - Nezhat, Camran

AU - Pejovic, Tanja

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological malignancies. Herein we present the latest information on the pathophysiology of ovarian cancer and its significance for ovarian cancer screening and prevention. A new paradigm for ovarian cancer pathogenesis presupposes 2 distinct types of ovarian epithelial carcinoma with distinct molecular profiles: type I and type II carcinomas. Type I tumors include endometrioid, clear-cell carcinoma, and low-grade serous carcinoma and mostly arise via defined sequence either from endometriosis or from borderline serous tumors, mostly presenting in an early stage. More frequent type II carcinomas are usually high-grade serous tumors, and recent evidence suggests that the majority arise from the fimbriated end of the fallopian tube. Subsequently, high-grade serous carcinomas usually present at advanced stages, likely as a consequence of the rapid peritoneal seeding from the open ends of the fallopian tubes. On the other hand, careful clinical evaluation should be performed along with risk stratification and targeted treatment of women with premalignant conditions leading to type I cancers, most notably endometriosis and endometriomas. Although the chance of malignant transformation is low, an understanding of this link offers a possibility of prevention and early intervention. This new evidence explains difficulties in ovarian cancer screening and helps in forming new recommendations for ovarian cancer risk evaluation and prophylactic treatments.

AB - Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological malignancies. Herein we present the latest information on the pathophysiology of ovarian cancer and its significance for ovarian cancer screening and prevention. A new paradigm for ovarian cancer pathogenesis presupposes 2 distinct types of ovarian epithelial carcinoma with distinct molecular profiles: type I and type II carcinomas. Type I tumors include endometrioid, clear-cell carcinoma, and low-grade serous carcinoma and mostly arise via defined sequence either from endometriosis or from borderline serous tumors, mostly presenting in an early stage. More frequent type II carcinomas are usually high-grade serous tumors, and recent evidence suggests that the majority arise from the fimbriated end of the fallopian tube. Subsequently, high-grade serous carcinomas usually present at advanced stages, likely as a consequence of the rapid peritoneal seeding from the open ends of the fallopian tubes. On the other hand, careful clinical evaluation should be performed along with risk stratification and targeted treatment of women with premalignant conditions leading to type I cancers, most notably endometriosis and endometriomas. Although the chance of malignant transformation is low, an understanding of this link offers a possibility of prevention and early intervention. This new evidence explains difficulties in ovarian cancer screening and helps in forming new recommendations for ovarian cancer risk evaluation and prophylactic treatments.

KW - endometriosis

KW - fallopian tube

KW - ovarian cancer

KW - prevention

KW - risk-reducing bilateral salpingo-oophorectomy

KW - salpingectomy

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=84940462511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940462511&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2015.03.044

DO - 10.1016/j.ajog.2015.03.044

M3 - Article

C2 - 25818671

AN - SCOPUS:84940462511

VL - 213

SP - 262

EP - 267

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -